via the HPV Roundtable Sharepoint site. ⢠HPV Resources Clearinghouse: Visit the Resources & Tools portion of the
The National HPV Vaccination Roundtable HPV vaccination is cancer prevention. Who are we?
HPV VACCINATION RECOMMENDATION from the Advisory Committee on Immunization Practices: Effective Oct. 2016
Boys and girls should receive 2 doses of HPV vaccine at ages 11-12.
We are a coalition of over 70 public, private, and voluntary organizations and experts dedicated to reducing incidence of and mortality from HPVassociated cancers in the United States. Our members include partners from diverse sectors including immunization, public health, academia, professional societies, industry, cancer prevention, and state and federal agencies among others. The HPV Vaccination Roundtable, managed by the American Cancer Society, launched in 2014 and in August 2016 received a five-year cooperative agreement from the CDC. What are our target long-term outcomes? Collectively, through our member organizations, we seek to:
Increase use of evidence-based strategies to increase HPV vaccination Increase use of tools that facilitate effective provider recommendations for HPV vaccination with a focus on girls and boys ages 11-12 Decrease missed opportunities for administration of HPV vaccine Contribute to increased HPV vaccination rates over time at national and state levels, including rates of series completion by age 13 Contribute to decreasing the gap between female and male HPV vaccination rates
The doses should be provided at 0 and 6-12 months apart. Two dose vaccination may be initiated as young as age 9, and through age 14.
How do we organize our work?
If the series is initiated at age 15 and older, 3 doses should be provided.
The National HPV Vaccination Roundtable develops and implements projects focused on overcoming barriers to HPV vaccination by focusing on five priority areas: providers, parents, systems, policies, and health disparities. We accomplish this through six task groups, and under the leadership of our Steering Committee. Current groups include:
Immunocompromised persons should receive three doses.
Best & Promising Practices Communications Electronic Health Records/Immunization Information Systems Empowering Parents & Allies Provider Engagement State Coalitions & Roundtables
Resources to Use
How many HPVattributed cancers are diagnosed each year in the U.S.?
Oropharyngeal Cervical Anal Vulvar Penile Vaginal
11,000 10,700 4,600 2,400 700 600
In addition, every year HPV contributes to:
1.4 million cases of lowgrade dysplasia 330,000 high risk cases of cervical dysplasia >300,000 cases of genital warts
Vaccination can prevent 80-90% of these cancers, pre-cancers and warts.
HPV Cancer Survivor Videos: The public now has access to a series of videos that give voice to HPV-cancer survivors who describe why it’s better to vaccinate adolescents than face treatment as middle-aged adults. http://bit.ly/HPVVideos
Report on HPV Vaccination Data Capture in EHRs/IIS: Learn about clinician and staff usage of electronic health records and state immunization information systems to capture HPV vaccination. http://bit.ly/HPVRT_EHRreport
Middle School Health Toolboxes: Middle school parents and school nurses can access new online toolboxes to encourage behaviors that promote adolescent health, including bundled messages on the importance of vaccines. www.middleschoolhealth.org
Provider Letters for Insurers: Insurers have an online toolkit of resources, including a “Dear Provider” letter that they can use to educate their members on the importance of HPV vaccination. http://bit.ly/HPV_Insurers
State Immunization Showcases: Iowa and Texas immunization programs shared their experiences with implementing innovative vaccination practices. These case studies will be available online.
HPV Vaccination Via Pharmacies Case Studies: Members commissioned work to explore how HPV vaccination may be operationalized in pharmacy settings. Case studies from Michigan and Iowa/KY/OR are available on our Sharepoint site. http://bit.ly/HPVRT_SP
HPV Vaccination Campaign: HPV vaccination partners now have a brandneutral “We’re In” messaging campaign and social media resources to use as part of their own efforts to increase HPV vaccination. Members can access via the HPV Roundtable Sharepoint site.
HPV Resources Clearinghouse: Visit the Resources & Tools portion of the HPV Clearinghouse website to access info from member organizations. http://bit.ly/HPVClearinghouse
Provider Education Modules: CME modules from member organizations are linked on the Clearinghouse site. New e-learning modules are anticipated in late 2016 for clinical teams to learn how to improve HPV vaccination in their practice and to hear how HPV-associated head and neck cancers are on the rise.
ContactUs: Email:
[email protected]
Website:
http://bit.ly/HPVRoundtable
